These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Vascular risk factors: a ticking time bomb to Alzheimer's disease. de la Torre JC Am J Alzheimers Dis Other Demen; 2013 Sep; 28(6):551-9. PubMed ID: 23813612 [TBL] [Abstract][Full Text] [Related]
23. The development, past achievements, and future directions of brain PET. Jones T; Rabiner EA; J Cereb Blood Flow Metab; 2012 Jul; 32(7):1426-54. PubMed ID: 22434067 [TBL] [Abstract][Full Text] [Related]
24. Lucentis using Visudyne study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration. Chen E; Brown DM; Wong TP; Benz MS; Kegley E; Cox J; Fish RH; Kim RY Clin Ophthalmol; 2010 Oct; 4():1073-9. PubMed ID: 20957143 [TBL] [Abstract][Full Text] [Related]
25. PET in Cerebrovascular Disease. Powers WJ; Zazulia AR PET Clin; 2010 Jan; 5(1):83106. PubMed ID: 20543975 [TBL] [Abstract][Full Text] [Related]
26. The contribution of neuroimaging to the study of language and aphasia. Lee A; Kannan V; Hillis AE Neuropsychol Rev; 2006 Dec; 16(4):171-83. PubMed ID: 17160697 [TBL] [Abstract][Full Text] [Related]
28. Use of spin echo T(2) BOLD in assessment of cerebral misery perfusion at 1.5 T. Kavec M; Gröhn OH; Kettunen MI; Silvennoinen MJ; Penttonen M; Kauppinen RA MAGMA; 2001 Mar; 12(1):32-9. PubMed ID: 11255090 [TBL] [Abstract][Full Text] [Related]
29. Limiting neurological damage after stroke: a review of pharmacological treatment options. Read SJ; Hirano T; Davis SM; Donnan GA Drugs Aging; 1999 Jan; 14(1):11-39. PubMed ID: 10069406 [TBL] [Abstract][Full Text] [Related]
30. Superficial temporal artery--middle cerebral artery anastomosis for acute cerebral ischemia: the effect of small augmentation of blood flow. Yoshimoto Y; Kwak S Acta Neurochir (Wien); 1995; 137(3-4):128-37, discussion 137. PubMed ID: 8789652 [TBL] [Abstract][Full Text] [Related]
31. Analysis of IMP-SPECT in cerebral infarcts. Watanabe Y; Takagi H; Oba M; Okubo M; Niwa T Neuroradiology; 1993; 35(6):412-5. PubMed ID: 8377909 [TBL] [Abstract][Full Text] [Related]
32. Assessment of pathophysiology of stroke by positron emission tomography. Heiss WD; Herholz K Eur J Nucl Med; 1994 May; 21(5):455-65. PubMed ID: 8062853 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers. Muir KW; Grosset DG; Gamzu E; Lees KR Br J Clin Pharmacol; 1994 Jul; 38(1):33-8. PubMed ID: 7946934 [TBL] [Abstract][Full Text] [Related]
36. Managing the hypertensive patient with cerebrovascular disease. Wood DH J Natl Med Assoc; 1984 Jul; 76 Suppl(Suppl):16-23. PubMed ID: 6471119 [No Abstract] [Full Text] [Related]
37. Hypoxia in patients with acute hemiplegia. Martin FC; Rudd AG Br Med J (Clin Res Ed); 1984 Mar; 288(6420):861. PubMed ID: 6423116 [No Abstract] [Full Text] [Related]
38. Treatment of acute stroke. Thomas DJ Br Med J (Clin Res Ed); 1984 Jan; 288(6410):2-3. PubMed ID: 6418298 [No Abstract] [Full Text] [Related]
39. Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. Brooks DJ; Leenders KL; Head G; Marshall J; Legg NJ; Jones T J Neurol Neurosurg Psychiatry; 1984 Nov; 47(11):1182-91. PubMed ID: 6334132 [TBL] [Abstract][Full Text] [Related]